Trademark: OMNIPODPROMISE 2230664
Word
OMNIPODPROMISE
ID
2230664
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
24 November 2021
Registration Date
24 November 2021
Renewal Date
24 November 2031
Owner(s)
Service
Spruson & Ferguson
Goods and Services:
Class 9:
Downloadable software in the nature of applications for mobile phone and smart phones for providing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management.
Downloadable software in the nature of applications for mobile phone and smart phones for providing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management.
Class 10:
Medical devices, including, drug delivery devices, namely, implantable drug delivery pumps and ports, sold empty, smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing, wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty, diabetes management devices, in the nature of blood glucose meters and glucometers, infusion pumps, infusion pump controllers and component parts and attachments thereof.
Medical devices, including, drug delivery devices, namely, implantable drug delivery pumps and ports, sold empty, smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing, wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty, diabetes management devices, in the nature of blood glucose meters and glucometers, infusion pumps, infusion pump controllers and component parts and attachments thereof.